Joint Commission Accreditation Survey

UroCor Patents

 UroCor licenses patents and seeks patents when appropriate on discoveries and inventions concerning new technologies, products and improvements.

1. Biomarkers and targets for diagnosis, prognosis and management of prostate disease. Patent number 5,882,864.  Issued March 16, 1999.  An G, O’Hara SM, Ralph DA and Veltri RW.  Assigned to UroCor, Inc.
2. Biomarkers and targets for diagnosis, prognosis and management of prostate disease. Patent number 5,972,615.  Issued October 26, 1999.  An G, and Veltri RW.  CIP of 5,882,864.  Assigned to UroCor, Inc.
3. Biomarkers and targets for diagnosis, prognosis and management of prostate disease. Patent number 6,171,796.  Issued January 9, 2001.  An G, and Veltri RW.  CIP of 5,972,615.  Assigned to UroCor, Inc.
4. Method for Selectively Inducing Biomarker Expression in Urologic Tumor Tissue for Diagnosis and Treatment Thereof. Patent Number 5,856,112.   Issued January 5, 1999.  Garry M. Marley and R.W. Veltri, Assigned to UroCor, Inc.
5. A sextant core biopsy predictive mechanism for non-organ-confined disease status”. Issued November 23, 1999. Patent Number 5,989,811.Veltri RW, Miller MC, Bacus MP, Ashenayi K. Assigned to UroCor, Inc.
6. Prediction of Prostate Cancer Progression by Analysis of Selected Biomarkers.  Issued February 15, 2000. Patent Number 6,025 128 . Robert W. Veltri, Michael P. Bacus, M. Craig Miller.  Assigned to UroCor Inc.
7. A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer”. Gang An and RW Veltri inventors.  “Contains claims to isolated nucleic acids from full-length UC41 gene sequence.  Assigned to UroCor.  Patent Number 6,156,515.
8. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast, and bladder cancer”. SN 09/662,270.  Gang An, Veltri RW et al inventors.   “Covers the full length UC28 gene” Patent allowed but not issued yet, issue fee Paid on 9/15/00. Assigned to UroCor. 
9. Diagnosis of disease state using mRNA profiles in peripheral leukocytes. David Ralph, Gang An, RW Veltri et al. Inventors.  Assigned to Urocor.  Patent Number 6,190,857.
10. Biomarkers for the detection of prostate cancer”. The patent claims methods for detection of prostate Cancer.  Patent No. 5,861,248 .  Issued on January 19, 1999.  University of Texas SW - Russell & AE Thigpen are the inventors), UroCor retains an option to license worldwide rights to seven prostate genes.